BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Enanta Pharmaceuticals, Inc. Announces Detailed Data From TURQUOISE-II Study In Chronic Hepatitis C Patients With Cirrhosis Being Presented At The European Association For The Study Of The Liver (EASL) Meeting 4/14/2014 9:41:13 AM    More...
Enanta Pharmaceuticals, Inc. Announces Data Presentations On Regimens Containing Protease Inhibitor ABT-450 To Be Presented At The European Association For The Study Of The Liver (EASL) Meeting 3/24/2014 8:33:51 AM    More...
Enanta Pharmaceuticals, Inc. Announces New Data Presented On Protease Inhibitor ABT-493 At The 21st Conference On Retroviruses And Opportunistic Infections (CROI) 3/5/2014 7:26:05 AM    More...
Enanta Pharmaceuticals, Inc. Release: PEARL-III Study Results In Patients With Chronic Hepatitis C Presented At The 21st Conference On Retroviruses And Opportunistic Infections (CROI) 3/3/2014 2:48:32 PM    More...
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal First Quarter Ended December 31, 2013 2/13/2014 8:02:51 AM    More...
Enanta Pharmaceuticals, Inc. Announces The Appointment Of George S. Golumbeski, Ph.D. To Board Of Directors 2/11/2014 10:12:23 AM    More...
Enanta Pharmaceuticals, Inc. To Present At The 2014 Leerink Swann and Company Global Healthcare Conference Presentation To Be Webcast On February 13, 2014 at 2:15 P.M. ET 2/6/2014 7:09:12 AM    More...
Enanta Pharmaceuticals, Inc. Announces The Appointment Of Timothy D. Ocain, Ph.D. As Senior Vice President, New Product Strategy And Development 2/4/2014 7:34:18 AM    More...
Enanta Pharmaceuticals, Inc. Announces Results From Four All-Oral, Interferon-Free, Phase 3 Studies For The Treatment Of Genotype 1 Hepatitis C Virus Infection 1/31/2014 9:22:33 AM    More...
Enanta Pharmaceuticals, Inc., No Longer Obscure, Eyes Slice Of Big Hepatitis C Market 1/24/2014 6:50:26 AM    More...
123456

//-->